Inflammatory cardiac fibroblast phenotype underlies chronic alcohol-induced cardiac atrophy and dysfunction

• Published in: Life sciences (1973) 2020-03, Vol.245, p.117330-10, Article 117330
• Main Authors: Mouton, A.J., El Hajj, E.C., Ninh, V.K., Siggins, R.W., Gardner, J.D.
• Format: Article
• Language: English
• Subjects: Activation; AKT protein; Alcohol; Animals; Atrophy; Blotting, Western; Cardiac atrophy; Cardiac fibroblasts; Cardiac muscle; Cardiac remodeling; Cardiomyocytes; Cardiomyopathies - chemically induced; Cardiomyopathies - pathology; Cardiomyopathies - physiopathology; Collagen (type III); Crosstalk; Echocardiography; Ethanol; Ethanol - adverse effects; Exposure; Fibroblasts; Fibroblasts - drug effects; Fibroblasts - pathology; Flow cytometry; Gene expression; Heart - drug effects; Heart - physiopathology; Heart failure; Inflammation; Inflammation - chemically induced; Inflammation - pathology; Inhalation; Male; Muscle contraction; Muscles; Myocardium - cytology; Myocardium - pathology; Myocytes; Phenotypes; Proteins; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Respiration; Structure-function relationships; TOR protein; Ventricle; Ventricular Remodeling - drug effects
• ISSN: 0024-3205; 1879-0631
• DOI: 10.1016/j.lfs.2020.117330

The purpose of this study was to investigate mechanisms of chronic alcohol-induced cardiac remodeling and dysfunction. We also sought to determine the role of cardiac fibroblasts, which play a dynamic role in cardiac remodeling, in mediating these effects. Adult male Wistar rats were exposed to ethanol (EtOH) vapor inhalation for 16 weeks. Echocardiography was performed to assess terminal cardiac structure and function. Cardiac fibroblasts were isolated from the left ventricle (LV) for both ex vivo and in vitro analysis. Cultured H9C2 cells were also exposed to conditioned media from alcohol-exposed cardiac fibroblasts. Gene expression in whole LV tissue, isolated cardiac fibroblasts, or cultured H9C2 cells was determined by real-time PCR, and protein expression was determined by Western blot. EtOH led to LV wall thinning and impaired systolic function, and decreased contractile protein mRNA levels. EtOH increased LV inflammatory markers, JNK and Akt activation, and decreased mTOR expression. EtOH induced myofibroblast activation as assessed by flow cytometry, and increased LV collagen III expression. EtOH increased expression of several inflammatory mediators in cardiac fibroblasts both ex vivo and in vitro. Administration of conditioned media from EtOH-treated fibroblasts decreased contractile protein mRNA levels and impaired Akt and mTOR signaling in differentiated H9C2 cardiomyocytes. Our results indicate that EtOH-induced cardiac atrophy and dysfunction is associated with activation of inflammatory pathways. Furthermore, EtOH may induce a pro-inflammatory cardiac fibroblast phenotype, leading to aberrant fibroblast-myocyte cross-talk. Thus, EtOH may promote cardiac muscle wasting in part by activation of pro-inflammatory fibroblasts.